Opportunity for Choice in the National Down’s Syndrome Screening Programme (NDSSP) Presented by: Nancy L. Chung.

Slides:



Advertisements
Similar presentations
© 2009 NHS National Genetics Education and Development CentreGenetics and Genomics for Healthcare This PowerPoint file contains.
Advertisements

Screening test of Pregnancy
Genetics and genomics for healthcare © 2012 NHS National Genetics Education and Development Centre Genetic testing: What is.
SOCIAL IMPLICATIONS OF GENETIC PRENATAL SCREENING IN PREGNANCY.
Antenatal Screening Mehreen Yousaf GP STS.
Fetal Testing During Pregnancy
Family Nurse Partnership
Prenatal Genetic Testing for Chromosomal Anomalies By: Linda DeFranco.
Clinical Applications of Genetic Tests Mikenzie Lewis.
Biochemical tests and ‘marker chemicals’
Pregnancy & Newborn Screening Developments
Problems During Prenatal Development & Prenatal Testing.
TEMPLATE DESIGN © Retrospective Analysis of Amniocentesis in UKMMC ZulidaR, MAJamil Universiti Putra Malaysia, UPM Serdang,
Annual Report and Accounts 2007/08 Item 5. Content Presentation of Annual Report –Key Facts about the RD&E –Key achievements –Key strategic priorities.
Cervical Sample Taker Training 2015 THE NHS CERVICAL SCREENING PROGRAMME (NHSCSP)
Professor Ken Stein Professor of Public Health University of Exeter Medical School (UEMS)
Module One: Introduction to the California Prenatal Screening Program
Suzanne Hodgson Researcher in Statistics & Epidemiology SCAAC – 12 June 2013 Updated Blastocyst Analysis.
An Ounce of Prevention  2000, 2005, 2011 The Curators of the University of Missouri Preconception Planning and Monitoring Fetal Health Twenty Questions.
Ante- and postnatal screening Antenatal care. Learning Outcomes A variety of techniques can be used to monitor the health of the mother and developing.
Engaging Pregnant Women to Stop Smoking – Creating Effective Referral Pathways and Increasing Quit Rates By Hayley Bates and Catherine Sixsmith.
2 Prenatal Tests: -Amniocentesis & -Chorionic Villus Sampling (CVS)
Screening for abdominal aortic aneurysm Sgrinio am ymlediadau aortig abdomenol Quality assurance of Imaging 23 rd April 2013 Author: G Davies.
Parents As First Teachers…. Can we do it! Introduction and Background Process Evaluation Identifying and engagement of clients Challenges Contact details.
1 Cervical Screening Programme, England, : Graphs.
C H A P T E R11 Antenatal screening of the mother and fetus The chapter aim s to: –discuss the principles of screening, good counseling techniques and.
Piloting local partnership arrangements between Mental Health services and the Work Programme Sandra Harrild Newham IAPT Clinical Lead.
NHS England New Structure and Industry Engagement Richard Stubbs Head of Commercial and International Innovation NHS England.
Ethics in obstetrics and gynaecology Dr Lisa Joels MD FRCOG Royal Devon & Exeter NHS Trust November 2011 © Royal College of Obstetricians and Gynaecologists.
Standard Grade Biology Inheritance Topic Chromosome Mutations.
Enabling Integration Dr David Paynton National Clinical Lead RCGP Centre for Commissioning.
Local and Strategic View Ann James, Chief Executive NHS Devon Devon Care Training Conference Tuesday 28 September 2010 Westpoint 09:55-10:10am.
TEMPLATE DESIGN © Reduced Fetal Movements as a Predictor of Fetal Compromise Dr. Meenu Sharma Lancashire Teaching Hospital.
NHS Fetal Anomaly Screening Programme Marie Coughlin Screening Lead January 25 th 2010.
Research Study Gavin Bryce Health Promotion Specialist NHS Brighton and Hove Provider-initiated HIV testing in primary care.
Antenatal (Prenatal) Screening Higher Human Biology Unit 2 – Human Physiology.
GENETIC DISEASES. Define disease abnormal condition affecting the body of an organism – may be caused by external factors or it may be caused by internal.
Learning to Manage Health Information Measuring the Quality of Maternity Care Professor Suzanne Truttero Midwifery Advisor Department of Health 18 th March.
CASE #887766S – The J. Smith Family
HIGHER HUMAN BIOLOGY Unit 2 Physiology and Health 1. Ante-natal Screening.
R ISK FACORS OF ADVANCED MATERIAL AGE R ISK FACORS OF ADVANCED MATERIAL AGE.
Prenatal Diagnosis affecting Pregnancy Decisions Sarah Jones Research in Allied Health.
Prenatal Screening By Karissa Parsons and Melissa Fakunle.
Quality Assurance for NHS Health Checks Sarah Stevens Public Health Registrar East of England QA Reference Centre.
Keith Reed - Tamba. About The Report Completed - Between August 2013 and February 2014 Responses – 3,728 responses from 6 countries Questions – Birth.
Higher Human Biology Unit 2 Physiology & Health KEY AREA 4: Ante- and Postnatal Screening.
UOG Journal Club: January 2016 Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results.
Ultrasound Best practice antenatal care for a woman who has no complications of pregnancy, involves referral for two screening-based ultrasounds a first.
Croydon Health Services
Figure 1: Classification of CNS abnormality (%)
A Commissioner’s Perspective
KnowDNA Innovating Prenatal Testing.
Prenatal monitoring.
The impact of ethnicity on presentation to antenatal care among pregnant women living with HIV in the UK and Ireland.
A – The reproductive system
Higher Human Biology Subtopic 12 Ante and postnatal screening
Addressing TB along the lifecycle – lessons from Uganda
Ziya Kalem,MD Gurgan Clinic IVF and Women Health Center
Obstetric and paediatric HIV surveillance data from the UK and Ireland
Genetic Testing Result Means. Before Genetic Testing  The result of genetic testing can be life changing.  It is important for patients and their families.
Obstetric and paediatric HIV surveillance data from the UK and Ireland
The women who died: UK Messages for the care of women who died between six weeks and a year after pregnancy.
Prenatal testing.
Local Implementation of NICE Guidance 6th December 2017
Obstetric / Specialist / Mother & Baby Care
Screening Division of Public Health Wales
Small steps to a healthy pregnancy
Dr Huda Muhaddein Muhammad
Nuchal translucency screening uses ultrasound to screen for Down syndrome, other conditions caused by an extra chromosome (trisomy 13 and 18), and congenital.
WHAT IS AVAILABLE WHEN? Non-invasive prenatal testing
Presentation transcript:

Opportunity for Choice in the National Down’s Syndrome Screening Programme (NDSSP) Presented by: Nancy L. Chung

The partners

The NHS FASP Established in National lead for antenatal screening for chromosomal and structural abnormalities. –Down’s syndrome screening – week ultrasound scan Accessibility Equality Quality Choice

Down’s syndrome screening

Commissioning tool Women with singleton pregnancy at 10 weeks Spontaneous miscarriage before screening offered Offered screening Spontaneous miscarriage Accept screening test Decline screening test High risk result Low risk result Down’s birth Other birth Go to 1 Accept CVS or amniocentesis Decline CVS or amniocentesis Positive test Negative test No procedural related miscarriage Procedural related miscarriage Go to 1 Accept TOP Decline TOP Go to 1 TOP Live Birth 1 Go to /16 weeks10 weeksTo term

NHS FASP benefits

PenTAG benefits (Peninsula Collaborations for Leadership in Applied Health Research and Care)

Associate benefits Health economics Modelling UK health care system

Conclusion Project is now in the pilot phase. Overwhelmingly positive response. Interest in sharing the tool and transfer to other UK screening programmes. National and international interest in the project. Setting FASP as an innovator.

Nancy L. Chung, BSc (Kinesiology), MBA, MHSA NHS FASP Innovation Centre Rennes Drive University of Exeter Exeter Devon EX4 3AG Thank you

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.